α—1b干扰素联合静脉丙球治疗新生儿病毒性肺炎疗效观察
作者：刘品
来源：《医学信息》2018年第03期

        摘 要：目的 探究α-1b干扰素与静脉丙球联合治疗新生儿病毒性肺炎的临床疗效。方法 选择我院儿科2014年12月～2015年12月收治的60例新生儿病毒性肺炎患儿，随机分为联合组和对照组，每组30例。对照组采用抗生素、抗病毒药物、吸氧等常规对症治疗，联合组在对照组基础上采用α-1b干扰素与静脉丙球联合治疗，观察两组患儿的临床治疗效果。结果 联合组总有效率为93.33%，明显高于对照组的76.67%，差异有统计学意义（P

        关键词：α-1b干扰素；静脉丙球；新生儿病毒性肺炎

        中图分类号：R722.1 文献标识码：A DOI：10.3969/j.issn.1006-1959.2018.03.050

        文章编号：1006-1959（2018）03-0142-02

        Abstract：Objective To investigate the clinical efficacy of α-1b interferon combined with intravenous propofol in the treatment of neonatal viral pneumonia.Methods From December 2014 to December 2015，60 neonates with viral pneumonia were randomly divided into combined group and control group.30 cases in each group.The control group was treated with antibiotics，antiviral drugs， oxygen inhalation and other routine symptomatic treatment，the combined group was treated with interferon α-1b combined with intravenous propofol on the basis of the control group，and the clinical effect of the two groups was observed.Results The total effective rate of the combined group was 93.33%，significantly higher than 76.67% in the control group，the difference was statistically significant（P

α—1b干扰素联合静脉丙球治疗新生儿病毒性肺炎疗效观察